The firm purchased topical products for the relief of diabetic neuropathy symptoms via its earlier acquisition of Cincinatti-based 40Js.
Gary Thompson, president and chief executive officer, said: " Diabetic neuropathy, or diabetic nerve pain, is a result of permanent damage to the nerves of the hand and feet caused by elevated blood sugar levels.
"This pain is different from pain you may have experienced from arthritis, a headache or even a sports injury."
He added it can affect the most simple of day-to-day activities for over 400 million people worldwide.
"Our product's innovative topical formulations of menthol and L-arginine paired with other key ingredients has been shown to ease this hand and leg pain. Our goal is to have distribution contracts in place and product shipping by mid summer."
The clinical-stage firm is developing innovative technologies for obesity and weight management.